Hypertension Trial, Recruiting NCT06558877 Sponsor: Xijing Hospital Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06558877
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People who have high blood pressure (measured on three separate days, with a top number of 140 or higher, or a bottom number of 90 or higher), who are already taking blood pressure medication but whose blood pressure is still not well controlled according to the study doctor
  • People who are comfortable using a smartphone and the WeChat app, including sending messages and uploading photos
  • People who are able to care for themselves, communicate normally, and are willing to work with the study team throughout the trial and any follow-up visits
  • People who live permanently in the city where the study centre is located
  • People who are willing to take part and sign a consent form

Who may not be able to join:

  • People with a serious advanced illness (such as those on dialysis or with liver failure), or whose life expectancy is estimated by the study doctor to be less than two years
  • People with a psychiatric condition, memory or thinking problems, communication difficulties, or who are otherwise unable to work with the research team
  • People who have had a stroke or cerebrovascular disease, or who have severe liver or kidney problems, severe heart failure, cancer, or a history of organ transplantation
  • People who are pregnant, breastfeeding, or planning to become pregnant within the next two years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613720451039

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xijing Hospital
Registry
ClinicalTrials.gov
Start date
20 June 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Blood pressure control rate; Time in target range (TTR); Medication Adherence; Cardiovascular events and all-cause death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov